{"filing":{"accession_number":"0001156039-26-000068","cik":"0001156039","ticker":"ELV","company_name":"Elevance Health, Inc.","form":"8-K","filing_date":"2026-10-21","report_date":"2026-10-21","primary_document":"elv-20261021.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603926000068/elv-20261021.htm"},"events":[{"id":36543,"run_id":33691,"accession_number":"0001156039-26-000068","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Elevance Health issued a press release on October 21, 2026 reporting third quarter 2026 financial results, including operating revenue of $50.4 billion, diluted EPS of $6.27, and raised full-year 2026 guidance for diluted EPS to at least $22.00 and adjusted diluted EPS to at least $29.00. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the earnings release furnished as Exhibit 99.1, which is the standard disclosure mechanism for quarterly earnings announcements.","company_name":"Elevance Health, Inc.","ticker":"ELV","filing_date":"2026-10-21","form":"8-K","submitted_at":null,"items":[{"id":40996,"accession_number":"0001156039-26-000068","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Elevance Health issued a press release on October 21, 2026 reporting third quarter 2026 financial results, including operating revenue of $50.4 billion, diluted EPS of $6.27, and raised full-year 2026 guidance for diluted EPS to at least $22.00 and adjusted diluted EPS to at least $29.00. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the earnings release furnished as Exhibit 99.1, which is the standard disclosure mechanism for quarterly earnings announcements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-21T10:07:48.069176+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":40996,"accession_number":"0001156039-26-000068","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Elevance Health issued a press release on October 21, 2026 reporting third quarter 2026 financial results, including operating revenue of $50.4 billion, diluted EPS of $6.27, and raised full-year 2026 guidance for diluted EPS to at least $22.00 and adjusted diluted EPS to at least $29.00. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the earnings release furnished as Exhibit 99.1, which is the standard disclosure mechanism for quarterly earnings announcements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-21T10:07:48.069176+00:00","company_name":"Elevance Health, Inc.","ticker":"ELV","filing_date":"2026-10-21"}]}